Then you may be interested in the SKYLIGHT clinical study. It will test how well an investigational drug works and how safe it is. This website will tell you what you need to know about being in the study. It will also tell you where the study takes place.
To learn more, click one of the buttons.
Postmenopausal women with vasomotor symptoms (hot flashes)
This website is for US residents only. Residents outside the US please go to clinicaltrials.gov for more information.
A study to find out how safe long-term treatment with fezolinetant is in women with hot flashes going through menopause
Please note that if you decide to participate in the study you can also choose to stop at any time.
Being part of a clinical study takes time and effort for the people in it and their caregivers. Here is important information you should know about the SKYLIGHT study:
The main purpose of the SKYLIGHT Study is to gather information about the investigational study drug, zolbetuximab (IMAB362), to see if it is effective in people with locally advanced unresectable or metastatic gastric or GEJ cancer when used in combination with an approved cancer treatment called mFOLFOX6.
Being part of the SKYLIGHT study takes time and effort for the person in it and their caregiver. You may:
This drug is experimental. Because of that, not all risks are known before starting a clinical trial. People who are in the study may stop at any time.
Based on your answers, you may be a candidate for this study.
To find the study center closest to you, enter your location below.
Based on your answers, this study may not be right for you. Please talk to your doctor if you still have questions about the SKYLIGHT study. Or, if you still think you may be a candidate for this study, search below for a study center near you.